These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5027223)

  • 1. [Estriol levels in the 3d trimester of risk pregnancies].
    Pontuch A; Lipenský S; Stencl J
    Cesk Gynekol; 1972 May; 37(4):260-1. PubMed ID: 5027223
    [No Abstract]   [Full Text] [Related]  

  • 2. Maternal serum unconjugated estriol and urine estriol concentrations in normal and high-risk pregnancy.
    Miller CA; Fetter MC; Boguslaski RC; Heiser EW
    Obstet Gynecol; 1977 Mar; 49(3):287-92. PubMed ID: 840456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum estriol levels in high risk pregnancy.
    Lox CD; Christian CD; Scott WC; Heine MW
    Ariz Med; 1973 Sep; 30(9):623-5. PubMed ID: 4755172
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical use of plasma total estriol measurements in late pregnancy.
    Hagerman DD
    J Reprod Med; 1979 Oct; 23(4):179-84. PubMed ID: 513042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rate meaning of estriol-dosage in the pregnant wife pointing out the phoetus development (author's transl)].
    Candi L; Cappiello R; Vallini A; Vernotico V; Davi D; Zanella B
    Quad Sclavo Diagn; 1976 Sep; 12(3):349-60. PubMed ID: 1025593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Critical analysis of fetal risk recognition by serum estriol determination].
    Distler W; Kiwit JC
    Z Geburtshilfe Perinatol; 1983; 187(4):168-74. PubMed ID: 6684842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioimmunological evaluation of maternal plasma levels of 17-beta-estradiol and estriol in normal and pathological pregnancies].
    Bolis PF; Polatti F; Di Mario M
    Arch Ostet Ginecol; 1974; 79(3-4):280-90. PubMed ID: 4471346
    [No Abstract]   [Full Text] [Related]  

  • 8. [The monitoring of risk pregnancies by E3 and HPL].
    Bieglmayer C; Spona J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():38-42. PubMed ID: 6211052
    [No Abstract]   [Full Text] [Related]  

  • 9. Estriol determinations in the management of high-risk pregnancies.
    Magendantz HG; Klausner D; Ryan KJ; Yen SS
    Obstet Gynecol; 1968 Nov; 32(5):610-9. PubMed ID: 5742475
    [No Abstract]   [Full Text] [Related]  

  • 10. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol.
    Santolaya-Forgas J; Jessup J; Burd LI; Prins GS; Burton BK
    J Reprod Med; 1996 Feb; 41(2):87-90. PubMed ID: 8656420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An algorithm for determining gestational age from unconjugated estriol levels.
    Buster JE; Freeman AG; Hobel CJ
    Obstet Gynecol; 1980 Nov; 56(5):649-55. PubMed ID: 7432738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester manifestation of intrahepatic cholestasis of pregnancy and high fetoplacental hormone production in a triploid fetus. A case report.
    Kirkinen P; Ryynänen M
    J Reprod Med; 1995 Jun; 40(6):471-3. PubMed ID: 7544410
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasma estriol in the surveillance of the second half of pregnancy. Report of 227 cases].
    Wolff F; Skoulios G; Frenkel H; Schick AR; Leissner P; Muller P
    Rev Fr Gynecol Obstet; 1973 Feb; 68(2):99-107. PubMed ID: 17471691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estriol reaction test for the diagnosis of fetal distress in the 3d trimester].
    Distler W; Brand H
    Z Geburtshilfe Perinatol; 1983; 187(1):17-22. PubMed ID: 6682593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring of at-risk pregnancies through E3 and HPL].
    Bieglmayer C; Spona J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():38-42. PubMed ID: 6242692
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA
    Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time trend analysis of unconjugated estriol concentrations in third-trimester pregnancy.
    Buster JE; Freeman AG; Tataryn IV; Hobel CJ
    Obstet Gynecol; 1980 Dec; 56(6):743-7. PubMed ID: 7443118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multifactorial pregnancy outcome index.
    Petersen LP; Witzke D; Gergen J; Kundu N
    Obstet Gynecol; 1984 Aug; 64(2):230-4. PubMed ID: 6738956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.